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Abstract 
-Lactoglobulin ( -Lg) is the major protein fraction of bovine whey serum and 
a primary gelling agent. -Lg has a high nutritional value, is stable at low pH 
being highly resistant to proteolytic degradation in the stomach, besides, it has 
the ability of acting as an encapsulating agent. This study aims at assessing the 
ability of -Lg nanostructures to associate a nutraceutical - i.e. riboflavin - and 
release it in a controlled manner throughout an in vitro gastrointestinal (GI) 
system. For this reason -Lg nanostructures loaded with riboflavin were 
critically characterized in terms of their morphology (i.e. size, polydispersity, z- 
potential and shape) by dynamic light scattering (DLS) and transmission 
electron microscopy (TEM), and efficiency to associate to riboflavin through 
spectrofluorimetry. Furthermore, these nanocomplexes were evaluated in an in 
vitro GI model, simulating the physiological conditions. Stable -Lg 
nanostructures were obtained at pH 6, of spherical shape, characterized by 
particle size of 172±1 nm, low polydispersity (i.e. PDI of 0.06±0.02), z-potential 
of -32±3 mV and association efficiency (AE) of 26±1 %. -Lg nano- structures 
showed to be stable upon their passage throughout stomach (i.e. particle size, 
PDI and z potential of 248±10 nm, 0.18±0.03 and 18±3 mV, respectively). 
Concerning their passage throughout the intestine, such nanostructures were 
mostly degraded in the duodenum. Regarding riboflavin, a release of about 11 % 
was observed after their passage through stomach, while 35 %, 38 % and 5 % were 
the released percentages of the total riboflavin associated observed after passage 
through duodenum, jejunum and ileum, respectively. Hence, -Lg 
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nanostructures showed to be suitable carriers for riboflavin until the intestine, 
where their degradation occurs. -Lg also showed to be structurally stable, under 
food simulant conditions (yoghurt simulant, composed of 3 % acetic acid), over 
14 days, with a protective effect upon riboflavin activity, releasing it in a 7 day 
period. 
 
1. Introduction 
 
Whey is a byproduct of cheese production, relatively inexpensive with a high 
nutritional value containing a variety of proteins with unique physical, chemical and 
functional properties (Cerqueira et al., 2014; McIntosh et al., 1998; Ramos et al., 
2015).  - Lactoglobulin ( -Lg) is the main protein in whey (i.e. 50% of whey protein 
composition), with a well-known ability to form three- dimensional networks (i.e. gel 
formation), foams and stable nano- structures. These nanostructures can associate 
to other compounds, thus improving their adsorption in the intestine by increasing 
residence time, enhancing contact with epithelial membrane, therefore contributing 
to a higher bioavailability (Diarrassouba, 2013;  Giroux & Britten, 2011;  
Gunasekaran, Ko, & Xiao, 2007). 
This  lipocalin protein  encompasses  nine  antiparallel  -barrels with three -
helixes on the outer surface, a free thiol group, responsible for its antioxidant 
activity and contains four binding sites (the calix, the gap near the a-helix on the 
outer surface, the dimer interface and the outer surface near tryptophane19- 
aginine124), which makes -Lg a suitable bio-based vehicle for transportation of 
various functional compounds, particularly those which are poorly soluble in 
water and susceptible to degradation by chemical and light reactions (such as 
riboflavin) (Diarrassouba, 2013; Diarrassouba, Liang, Remondetto, & Subirade, 
2013; Giroux & Britten, 2011; Madureira, Pereira, Gomes, Pintado, & Malcata, 2007;  
Zimet  & Livney, 2009). 
Structures used in the nanometer scale exhibit a large surface area-to-volume 
ratio and their physical and chemical interactions influence their overall properties, 
in particular encapsulation of nutraceuticals. For instance, a change in their 
pharmacokinetics and biodistribution, contributes to the improvement of 
nutraceuticals’ solubility and bioavailability, thus preventing undesirable chemical 
reactions and maintaining its activity until its release (Cerqueira et al., 2014; 
Lingyun Chen, Remondetto, & Subirade, 2006; Ramos et al.,  2015). 
Riboflavin (also known as vitamin B2) is a biocompatible flavin that can easily be 
found in Nature (in wheat bran, meat, milk, cheese and plant materials). This 
vitamin is essential for growth, development and normal maintenance of the human 
body, but  very susceptible to light degradation and poorly soluble in water (Ball, 
2004; Cerqueira et al., 2014; Diarrassouba et al., 2013). On the other hand, upon light 
activation, riboflavin can also cause damage to DNA, proteins and other 
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biomolecules. Therefore, this vitamin can effectively act as a nutraceutical against 
antibiotic resistant pathogens found in food products and in prevention of some types  
of cancers (e.g. leukemia) (Diarrassouba et al., 2013). When ingested, the 
-Lg/riboflavin nanocomplex will be subjected to innumerous conditions (i.e. pH 
variations, enzymatic action, peristaltic movements and temperature), in the 
gastrointestinal (GI) tract, that can change their structure, thus reducing their 
effectiveness. Therefore, it is crucial to evaluate the behavior of such nano- complex 
in the GI tract physiological conditions in order to understand the effects on the 
nanostructure stability, in particular regarding the release of riboflavin with the 
purpose of optimizing  its bioavailability (Cerqueira et al., 2014). 
Studies were found in the literature addressing complexes made from whey 
proteins and bioactive compounds under GI conditions. Diarrassouba et al. (2013) 
studied the effects of GI pH conditions on the stability of -Lg/vitamin D3 
nanocomplex. They concluded that  -Lg/D3 nanocomplex is stable under acidic 
(4.0-2.5) and alkaline (6.8-8.0) transitions, suggesting that it might be stable 
throughout the GI tract transit. Picot and Lacroix (2004) studied the encapsulation 
efficiency of bifidobacteria in whey protein-based micro- capsules and their survival 
in simulated GI conditions. They concluded that encapsulation of bifidobacteria 
provided a protective effect during the GI simulation (i.e. pH 1.9 and gastric enzymes 
e in stomach simulation; and pH 7.5 and pancreatic and bile salts e in intestinal 
simulation) tested at 37 oC. Le Maux et al. (2013) studied the  -Lg/linoleate complex 
under in vitro digestion conditions (0.15 mol/L NaCl and pH 2.5 e gastric fluid 
simulation; and 0.15 mol/L NaCl and pH 6.5 - duodenal fluid simulation), linoleate 
bioaccessibility, as well as its intracellular transport into intestinal epithelial 
Caco-2 cell lines. They concluded that the formation of - Lg/linoleate complex 
modified the linoleate transport and delayed the cytotoxicity of the fatty acids. 
However, the GI models used in these studies only mimic the gastric and duodenal 
conditions being poorly accurate regarding GI tract enzymatic conditions. 
Therefore, the present work intends to go deeper in this matter in order to better 
understand the behavior of bio-based nanostructures, as well as the 
bioavailability of associated bioactive compounds, when subjected to different 
physicochemical mechanisms. Hence, nano- structures made from -Lg and 
loaded with riboflavin were critically characterized in terms of their morphology 
(i.e. particle diameter, polydispersity and z-potential, shape) by dynamic light 
scattering (DLS) and transmission electron microscopy (TEM), and the efficiency 
to associate riboflavin by spectrofluorimetry. Furthermore, these nanocomplexes 
were evaluated through an in vitro GI model, simulating the physiological 
conditions (i.e. pH, enzymes, salts and temperature) and time in the stomach and 
small intestine (including duodenum, jejunum and ileum) in order to address the 
main challenges regarding the bioavailability of riboflavin and its controlled release 
4 
 
in different GI conditions. This study also provides information about the stability of 
such nano- complexes when incorporated in water (used as control) and in a food 
model system (i.e. yoghurt) during 14 days of storage, aiming at their application in 
the food  industry. 
 
2. Materials  and methods 
 
2.1. Materials 
 
Riboflavin with a purity 98% and bovine -Lg containing variants A and B 
(36.0 kDa) with a purity 90% (L0130), were purchased as a lyophilized powder 
from Sigma-Aldrich (St. Louis MO, USA).  Pepsin  (600  U  ml-1)  from  porcine  
gastric  mucosa,  lipase (40  U  ml-1),  pancreatin  from  porcine  pancreas  (8       
USP),  bile extract porcine, as well as gastric and small intestinal electrolyte 
solution salts were also purchased from SigmaeAldrich (St. Louis MO, USA). 
Ultrapure water (resistivity 18.2 MU/cm) was obtained with a Milli-Q Ultrapure 
water purification system (Millipore, Bedford MA, USA). Sodium hydroxide (NaOH) 
and hydrochloric acid (HCl) solutions were obtained from Panreac (Panreac Quimica 
SA, Barcelona, Spain). Coomassie brilliant blue (250) (CBB) was purchased from 
Sigma-Aldrich (St. Louis MO, USA), whereas sodium azide (NaN3) was obtained 
from Merck (Darmstadt, Germany). All other chemicals were reagent-grade or 
higher, and were used without further purification. 
 
2.2. Measurements 
 
2.2.1. Dynamic  light scattering 
The particle diameter, polydispersity index (PDI) and z-potential of protein 
solution were measured by dynamic light scattering  (DLS) using a Zetasizer Nano 
ZEN 3600 (Malvern Instruments, Worcestershire, UK) equipped with a HeeNe laser 
of 632.8 nm and 4 mW. Measurements of DLS were collected applying backscatter 
detection NIBS (Non-Invasive Back-Scatter) at 173o, which reduces multiple 
scattering and allows higher concentrations to be measured (Rodrigues et al., 2015). 
Samples (1 mL) of unheated and heated -Lg solutions collected at different stages 
of in vitro digestion were poured into disposable sizing cuvettes with a path length of 
12 mm for particle diameter and PDI determination and into a folded capillary cell 
for -potential analyses and measurements were carried out, at least, in triplicate. 
To analyze the samples resulting from the in vitro digestion experiment, a dilution of 
a 1:100 (v/v) ratio was made in the appropriate pH conditions (pH 2 and 7 for stomach 
and small intestine, respectively) to avoid multiple scattering effects. The 
temperature of analysis was maintained at 25.0 ± 0.5 oC during measurement. 
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Average diffusion coefficients were determined by the method of cumulants fit and 
were translated into average particle diameters (Zavg) using Stokes-Einstein 
relationship (Rodrigues et al., 2015). PDI derived from cumulants analysis of the DLS 
measurements was also evaluated and describes the width or the relative variance 
of the particle diameter distribution. The -potential was performed with an angle of 
17o by measuring the velocity and direction of droplet movement in the electric field  
being calculated through  the Smoluchowski   model. 
 
2.2.2. Transmission electron microscopy 
The surface morphology of the -Lg nanostructures was evaluated by 
transmission electron microscopy (TEM) (Zeiss EM 902A Thornwood, N.Y., USA) at 
an accelerating voltage of 50 and 80 kV. The samples were previously prepared by 
dropping -Lg samples onto  copper  grids  coated  with  carbon  film,  followed  by  
natural drying for 2 min and the excess was removed with absorbent paper. The 
samples were then negatively stained with uranyl acetate (2% w/w) (Merck, 
Germany) for 15 s, and the grid was air-dried at room temperature   before   
introducing   it   in   the   electron microscope (Bourbon et al., 2015;  Pinheiro et  al., 
2015). 
 
2.2.3. Spectrofluorimetry 
Spectrofluorimeter (Jasco FP6200, Tokyo, Japan) was used to assess the 
association efficiency of riboflavin, and to quantify its release over time during 
the in vitro digestion and stability assays. 
This vitamin presents fluorescence properties (Sa', da Silva, Jost, & Spinelli, 
2015), which enable its study on a spectrofluorimeter. All samples were previously 
centrifuged at 5000 g, for 30 min at 5 oC to separate the -Lg nanostructures from 
free riboflavin in order to avoid misleading results. The fluorescence intensity 
spectra of supernatants were then recorded between 480 and 650 nm, with an 
excitation wavelength set to 450 nm. 
 
 
2.2.4. Native  polyacrylamide  gel electrophoresis 
In order to understand the behavior of -Lg in GI conditions, a native 
polyacrylamide gel electrophoresis (native PAGE) was per- formed. The native PAGE 
was carried out using the Mini-Protean II dual slab cell system equipped with a PAC 
300 power supply (Bio- Rad Laboratories, Hercules, CA, USA). The resolving and 
stacking gel contained 12% and 4% of polyacrylamide, respectively. The gels were 
left in gentle agitation overnight in a solution of ethanol 50% and acetic acid 10% 
and stained with CBB and destained with a 30 and 7% of ethanol and acetic acid 
solutions, respectively, according to previous works (Bourbon et al., 2015; L. Chen & 
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Subirade, 2005; Rodrigues et al., 2015). 
 
2.3. -Lg/riboflavin nanocomplex 
 
2.3.1. Production 
-Lg nanostructures were prepared according to previously optimized 
conditions (Branco, 2015) where various parameters were assessed (i.e. protein 
and vitamin concentrations, time of heating, centrifugal time and g force 
employed). Therefore, a solution of -Lg at 0.5% (w/v) was prepared via 
dissolution in ultra- pure water and subsequently stirred for 2 h at room 
temperature, and then pH was adjusted to 6.0 with HCl (1 mol/L) or NaOH (1 mol/ 
L), as necessary. Afterward, the -Lg solution was heated at 80 oC for 10 min. A 
riboflavin solution was finally added to attain a final concentration of 0.0006% 
(v/v). During this process, the vitamin solution was protected from light exposure 
with aluminum foil. The resulting solution was then cooled in ice for 15 min. 
 
 
2.3.2. Association efficiency 
Association efficiency (AE) was assessed by comparing the total riboflavin 
concentration (from riboflavin solution) with the con- centration of riboflavin 
unattached to -Lg. Primarily, 1 mL of both riboflavin at 0.0006% (v/v) (riboflavin 
solution), and samples (-Lg/ riboflavin nanocomplex) were placed into Eppendorf 
tubes and centrifuged. Then, 0.1 mL of supernatant was collected and 
fluorescence spectral analysis was obtained. The maximum absorbance peaks, 
from the fluorescence spectra, of riboflavin and supernatant were used to 
determine the riboflavin concentration (calculated using     an     appropriate     
calibration     curve     of  riboflavin: y=99,624x + 8.3344, R2=0.991; being y and x 
the absorbance and concentration of free riboflavin, respectively) and the results 
were used on Eq. (1). 
 
 
where CVit.total represents the concentration of riboflavin in solution and 
CVit.free the concentration of free riboflavin separated from -Lg nanostructures 
The determinations were performed at least in triplicate. 
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2.4. In  vitro digestion 
 
The in vitro digestion experiment was performed in a GI model constituted  by  a  
double-walled  water-jacketed   reactor   vessel (10 cm internal diameter and 15 cm 
height), adapted from Pinheiro et al. (2013). Primarily, the loss of activity of free 
riboflavin was assessed in the in  vitro  GI  model  and it  was  observed that only  56 
± 10, 40 ± 8, 24 ± 3 and 16 ± 4% would reach the stomach, duodenum, jejunum and 
ileum, respectively. These results confirm the necessity of its encapsulation in order 
to allow its protection during the in vitro digestion. -Lg/riboflavin solution (40 mL) 
was inserted into the GI simulator, the temperature was set to 37 oC and appropriate 
secretions were continuously added, in order to mimic the physiological conditions of 
the GI tract (i.e. stomach, duodenum, jejunum and ilium). All samples were taken at 
the end of each phase. The in vitro digestion conditions are resumed in Table 1. All 
pH transitions were accomplished by adding HCl (1 mol/L) and sodium bicarbonate 
(1 mol/L) for gastric and small intestine pH conditions, respectively. 
 
2.5. Stability assessment 
 
The stability of -Lg/riboflavin nanocomplex was assessed in a food model 
system solution composed by 3% of acetic acid at pH 3.65, to mimic yoghurt, 
according to the Commission Regulation (EU) No 10/2011 for food simulants 
(European Commission, 2011), and compared with the behavior of such 
nanocomplex in ultrapure water (used as control). The stability test was 
conducted during a predetermined period of time (14 days) through evaluation of 
particle diameter, PDI and z-potential variation by DLS, release profile of 
riboflavin by spectrofluorimetry, and particle morphology by TEM. 
Microorganism growth was prevented by adding 0.02% of NaN3 (used as 
preservative) (Ramos et al., 2012) into the food model system solution. All 
samples were analyzed immediately after production, in triplicate. 
 
2.6. Statistical  analysis 
 
All statistical analyses involving experimental data were per- formed using 
Statistica software version 10.0.228.8 (StatSoft Inc.). Statistical significance (at p 
≤0.05) was determined using one-way ANOVA followed by post hoc. 
Tukey's tests. Unless otherwise stated, all the following experiments were run 
at least in triplicate and all measured parameters are means of four experimental 
points. 
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3. Results  and discussion 
 
3.1. Particle characterization 
 
The evaluation of particle diameter, PDI and -potential allowed the 
understanding of some structural changes that occur in -Lg nanostructure during 
the heating treatment and incorporation of riboflavin. Characterization of -
Lg/riboflavin nanocomplex by DLS is shown in Table 2. 
These results demonstrate that unheated -Lg solution, at pH 6, presents a 
significant degree of heterogeneity (confirmed by the high standard deviation 
obtained for particle diameter and PDI values). This heterogeneity may be due to 
non-covalent linked protein aggregates which are commonly observed on its native  
form (Pereira, Souza, Cerqueira, Teixeira, & Vicente, 2010; Ramos et al., 2014). This 
protein system appears to be on a semi-stable state when looking to the -potential 
value (-20 ± 5 mV) e it is considered   that   z-potential   values   above   30   mV    
and   below 30 mV, for this kind of nanostructures, represent stable colloidal systems 
(Diarrassouba, 2013; Moore & Cerasoli, 2010). However, this colloidal stability can 
always be compromised with interaction of oppositely charged polymers and 
particles. Denaturation was then promoted by heating the -Lg solution (80 oC for 
10 min), which caused alterations on particle diameter, PDI and z- potential. After 
heating, the protein solution became more stable (z-potential changed from 20 ± 5 to 
33 ± 7 mV)  and homogeneous.   Moreover,   PDI   values   decreased   from   0.54   ±  
0.02 to 0.08 ± 0.03 and particle diameter was reduced approximately to half of its 
initial value (i.e. decreased from 299 ± 25 to 168 ± 3 nm). The heating process may 
allow dissolving some protein aggregates that could be present in the native solution 
at ambient temperature, while also promoting structural rearrangements by 
breaking at least some of the disulfide bonds, resulting in protein unfolding and 
exposure of its sulfhydryl groups. The sulfhydryl groups may form inter- and intra-
molecular bonds by interacting with other disulfide bonds which, together with inter-
molecular interactions between  proteins,  will  determine  protein  aggregation   
(Pereira et al., 2010). After cooling, aggregation  of  -Lg  occurs (Kolakowski, Dumay, 
& Cheftel, 2001) through new intramolecular disulfide bonds leading to the reduction 
of particle diameter distribution. The addition of  riboflavin  did  not  produce  
significant (p > 0.05) changes in the particle diameter, PDI or -potential values (see 
Table 2). Incorporation of riboflavin into the solution was made while -Lg was on 
its molten globule state. At this state, the partial unfolding of -Lg and the increase 
in flexibility of some structural regions (but still preserving the calyx) enables the 
exposure of the inner binding site, making it more easily accessible (Tavel, Moreau, 
Bouhallab, Li-Chan, & Guichard, 2010) to riboflavin, which possibly allowed its  
association  to  the  protein  network  with  an  AE  of  26 ± 1%. This value was 
9 
 
relatively lower when compared with that obtained by Azevedo, Bourbon, Vicente, 
and Cerqueira  (2014), which showed an AE of 56 ± 6% for riboflavin using 
nanoparticles made from alginate/chitosan as base materials, besides a high 
heterogeneity associated to these systems (Azevedo et al., 2014). This difference 
could be explained by the nature of the different encapsulating agents employed 
(in that case, the authors used the combination of two polysaccharides for the 
nanostructures production), as well as by the different production conditions (e.g. 
pH of 4.6 and 4.9) applied. It is known that, despite the lack of toxicity, the 
recommended daily dose (RDD) for riboflavin is approximately 1.2 mg (Horwitt, 
Harvey, Hills, & Liebert, 1949; Powers, 2003). Therefore due to an AE of 26 ± 1%, 
the results show that 12% of the RDD would reach the small intestine if 100 mL 
of a food product was ingested, suggesting that this nanocomplex may find 
applications as a food supplement system. Hence, it can be incorporated into 
healthy food products that have already some content of riboflavin in their 
composition in order to overcome potential nutritional deficiencies. 
Despite of the fact that the nanocomplex produced here showed to be more 
stable than those reported elsewhere, comparisons should be carefully made once 
conditions/compounds employed and purposes vary significantly (Pereira et al., 
2010). Yi et al. (2014) produced -Lg/dextran nanoparticles for controlled release 
of - carotene. They obtained -Lg/dextran nanoparticles with a mean particle 
diameter of 68 ± 3 nm, PDI of 0.17 ± 0.03 and -potential of 14 ± 1 mV. They 
obtained a lower particle diameter than those mentioned in this work. That can 
be explained by different sample preparation or conditions used (i.e. 
nanostructures formed by the mixture of different polymers - dextran and -Lg - 
prepared at pH 7 and -Lg at 1%). However the nanocomplex formed seems to be 
less stable(z-potential of 14 ± 1 mV) according with the definition of stability for 
colloidal systems aforementioned (Diarrassouba, 2013; Moore & Cerasoli, 2010), 
thus being probably less suitable as carrier systems for nutraceuticals, when 
compared with the results presented here for -Lg nanostructures (Table 2). Chen 
and Subirade (2005) produced chitosan/-Lg core-shell nanoparticles for 
controlled release of nutraceuticals. They studied the influence of pH on particle 
diameter and -potential. At pH 6.1, they obtained a particle diameter of 103 nm, 
PDI of 0.54 and -potential of 30 mV. Despite the lower particle diameter 
obtained (which can be explained by the nanocomplex formation between 
chitosan and - Lg) their nanosystem presented a high degree of heterogeneity 
which suggests the existence of particles on other scale ranges. Thus, the authors 
cannot assure the measurement of particles only in the nanometer range. 
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3.2. In  vitro digestion 
 
During digestion, food undergoes two main processes (that occur 
simultaneously): the influence of mechanical movements (i.e. peristaltic 
movements) to reduce the diameter of food particles, and enzymatic action where 
macromolecules are hydrolyzed to form more basic, smaller structures able to be 
subsequently absorbed into the bloodstream (Guerra et al., 2012; Kong & Singh, 
2008; Pinheiro, 2013). 
In  order  to  understand  the  behavior  of  -Lg  nanostructures loaded with 
riboflavin in GI conditions, an in vitro GI model was used to simulate as close as 
possible the human GI tract. Therefore, said nanostructures were characterized in 
terms of their structure (i.e. particle diameter, PDI and -potential), capacity to 
associate to and  release riboflavin. 
 
3.2.1. Structural characterization of -Lg nanostructures 
A structural analysis was made in order to understand the influence of digestion 
conditions on -Lg nanostructures loaded with riboflavin, resorting to DLS 
measurements, and the results are depicted in Table 3. 
From the DLS results depicted above, it was possible to observe that b-
Lg/riboflavin nanocomplex possibly suffered aggregation throughout the digestive 
process, as well as an increase in its het- erogeneity. These findings are inferred from 
the increase in particle diameter and PDI values, respectively, along the passage 
through the different GI conditions. Although, it was not possible to deter- mine the 
precise mechanism that caused the structural changes in the nanostructures but the 
increase in particle diameter could be explained by the presence of bile salts, 
digestive enzymes, or by the combined effect of pH and ionic strength (Pinheiro, 
2013). During the stomach step, -Lg nanostructures were subjected to enzymatic 
digestion (pepsin and lipase) and acidic pH conditions (from 4.8 to 1.7), which 
influence the conformation of  the  nanostructure,  as well as its -potential. The 
passage through the pI value of -Lg (pH of 5.2) may influence its structure and can 
be the cause of the particle diameter difference between the initial and gastric 
conditions (Griffin, Griffin, Martin, & Price, 1993) and its surface charge, observable 
on the transition from a z-potential value of    37  ± 1    to 28 ± 2 mV (i.e. pH values 
below pI promote a positively charged protein surface) (Diarrassouba, 2013). Despite 
of the changes, when comparing with the initial state, the nanostructure remained 
homogenous and stable supported by low PDI value (ca. < 0.2) and high z-potential 
value (ca. 30 mV), respectively e see Table 3. To confirm the results obtained by DLS, 
a native PAGE was performed e see Fig. 1 - since it enables the separation of -Lg 
aggregates by charge, particle diameter and shape (Rodrigues et al., 2015). 
From the analysis of Fig. 1, it is possible to observe that in lane 1, unheated -Lg 
nanostructures are more likely to aggregate at pH 6, which is near the pI of -Lg 
11 
 
(i.e. pH value of 5.2) which leads to the formation of small and unstable protein 
aggregates (Diarrassouba, 2013). Smears in lane 2 can be attributed to heat 
denaturation of native -Lg and concomitant appearance of high molecular mass 
protein aggregates as reported elsewhere (Rodrigues et al., 2015). Comparing 
lane 2 (-Lg/riboflavin nanocomplex) used as control with lane 4 (-Lg/riboflavin 
nanocomplex in stomach), is quite evident the presence of -Lg/riboflavin 
nanocomplex in the stomach phase. This may indicate that -Lg nanostructures are 
resistant to proteolytic and pH conditions of stomach. In lane 4, protein smears may 
result from acid aggregation during transition through isoelectric point, promoted 
by the in vitro stomach pH conditions. From lane 5 to 8, -Lg/riboflavin nanocomplex 
was not observed when compared with lane 2 (control), which may  indicate  that 
such nanocomplex was completely degraded in the intestinal phase of the GI system, 
possibly as soon as  it  reached  the  duodenum (Fig. 1). Despite of -Lg endurance in 
the stomach, during intestinal digestion -Lg is very susceptible to small intestine 
enzymatic hydrolysis (i.e. pancreatin), which leads to -Lg digestion in the small 
intestine (Fu, Abbott, & Hatzos, 2002; Mandalari et al., 2009). The loss of color 
progressively observed from lane 6 to 8 may be due to the dilution effect of the 
samples, as a consequence of in vitro digestion protocol (constant addition of 
electrolyte solutions) (Pinheiro et al., 2013). 
The DLS and electrophoretic results suggest that -Lg is resistant to enzyme 
digestion in the stomach. This resistance can be explained by the fact that most 
hydrophobic amino acids are buried inside the b-barrel, due to its stable globular 
tertiary structure, which makes pepsin digestion a more difficult process (Bateman,  
Ye, & Singh, 2010; Peram, Loveday, Ye, & Singh, 2013). Regarding the passage of 
-Lg through the small intestine, the DLS analysis could be misleading. Due to high 
PDI values in the small intestine (probably due to the presence of bile salts and 
enzymes), DLS analysis may not be the best analytical method to measure the 
structural changes that may occur in the small intestine phase. Therefore, the 
electrophoretic technique was performed and the results showed that -Lg 
nanostructures were degraded in the duodenum since the correspondent band is not 
observable on the subsequent digestion stages. This behavior was also reported by 
other authors (Bossios et al., 2011; Fu et al., 2002; Islam, Ekeberg, Rukke, & 
Vegarud, 2015). Fu et al. (2002) studied the digestibility  of food allergens and non-
allergenic proteins under simulated GI conditions. One of the food allergens studied 
was -Lg which showed to be highly resistant to gastric digestion but rapidly 
degraded in the small intestine, being mostly digested by pancreatic enzymes. 
Bossios et al. (2011) studied the effect of simulated GI conditions on the allergenic 
reactivity of -Lg. They concluded that -Lg resisted the harsh gastric conditions but 
was susceptible to pancreatic enzymes in the small intestine. Islam et al. (2015) 
studied  the  in  vitro  digestion  of  milk  focusing on proteolysis  and lipolysis. They 
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observed that -Lg was resistant to pepsin digestion but was degraded by pancreatic 
enzymes. They also concluded that bile salts influence significantly the digestion of 
-Lg. 
In this work, it was shown that -Lg is a bio-based carrier that has the ability 
to protect an active compound from gastric conditions (i.e. acidic pH and 
enzymatic activity). In contrast, under intestinal conditions, our results and 
reports described elsewhere indicate that -Lg and its genetic variants are 
degraded mainly due to bile salts concentration and presence of pancreatin that 
influences its digestion rate (Bossios et al., 2011; Fu et al., 2002; Islam et al., 2015). 
Therefore, it should be expected that riboflavin release took place in the small 
intestine. As such, in order to verify this hypothesis, the release profile of 
riboflavin was determined during GI simulation and the results are reported 
below. 
 
3.2.2. Release profile of riboflavin 
During in vitro digestion, the release profile of riboflavin was evaluated in order 
to identify the precise location and quantify its release. 
Fig. 2 shows that only 11 ± 2% of riboflavin was released during the gastric phase; 
this result was somehow expected due to -Lg resistance to gastric conditions. On 
the other hand, higher amounts of riboflavin were released in the duodenum, 
jejunum and ileum, corresponding to 35, 38 and 5% of the total riboflavin 
encapsulated, respectively. These results are in accordance with the results obtained 
by native-PAGE, which showed the degradation of -Lg mostly in the small intestine. 
The results presented above show that most riboflavin was released during 
duodenum and jejunum phases (35 and 38%, respectively). Being part of the 
small intestine, the main role of duodenum, jejunum and ileum is to breakdown 
food constituents into smaller compounds. These compounds are then absorbed 
through the intestinal walls and the waste products (non-absorbed substances) 
pass into the large intestine for excretion (Pinheiro, 2013; Thomson, Shaffer, & 
Gonska, 2014). Since most of the riboflavin was released in the duodenum and 
jejunum, it is most likely that riboflavin would be mostly absorbed by the 
intestinal walls, into the bloodstream. 
These results confirm that -Lg nanostructures can act as protective carriers 
against gastric conditions, which will allow enhancing the bioavailability of 
riboflavin and thus improving its absorption in the small  intestine. 
 
3.3. Evaluation  of  -Lg /riboflavin stability 
 
A stability study was conducted in food simulant conditions to evaluate    the    
behavior    of    -Lg over time, mimicking  its incorporation in a food product under 
storage conditions. A structural evaluation of the nanocomplex and a release profile 
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were obtained and the results are shown in Figs. 3 and 4 and Fig. 5, respectively. 
Fig.  3  shows  that  particle  diameter,  PDI  and  -potential, remained 
approximately constant during the experiment time with mean particle diameters 
of 202 ± 7 and 232 ± 4 nm, PDI values of 0.11  ± 0.04  and  0.09  ± 0.03,  and  -
potential  values  of  -37  ± 2 and +37 ± 1 mV, for water and food simulant 
conditions, respectively. Moreover, the results showed that -Lg, slightly 
aggregated under food simulant conditions when compared with water 
conditions (mean particle diameter  of  202  ±  7  nm  instead  of  232 ± 4 nm in 
water and food simulant conditions, respectively). This smaller aggregation could 
be explained by the effect of acetic acid in the protein unfolding properties 
(Borkar, Rout, & Hosur, 2012; Liao et al., 2010), which could possibly enable 
protein aggregation by inducing the formation of intermolecular bonds 
(Rodrigues et al., 2015). Since we are working with acetic acid at low 
concentration, the differences observed between water and food simulant 
conditions were not too prominent. In spite of this, the solution remained 
homogeneous, with a low PDI value in both water and simulant conditions. Thus, 
the food simulant conditions did not significantly  change  the  homogeneity  of  
the  solution (p < 0.05). Regarding the z-potential, the change between a negative 
surface charge (water conditions) to a positive surface charge (simulant 
conditions) can be explained by the different pH of the solutions (pH 6 and 3.65, 
above and below the pI of -Lg, for water and simulant conditions, respectively) 
(Diarrassouba, 2013; Donato, Schmitt, Bovetto, & Rouvet, 2009). These results 
were corroborated with TEM micrographs (Fig. 4). 
These images indicate that -Lg nanostructures have a spherical shape, with a 
particle diameter of ca. 200 nm (in accordance with DLS measurements) in both 
water and food simulant conditions, suggesting that -Lg nanostructures are 
resistant to food simulant conditions. It is also possible to observe that -Lg suffered 
some structural changes in water (when compared with  time  0  from Fig. 4), 
imperceptible on DLS analysis. It is noticeable that -Lg in water formed crystal 
shaped structures after 14  days of storage at  4 oC. Proteins in aqueous solutions 
tend to quickly aggregate (due to protein unfolding) when submitted to low 
temperatures (Kolakowski et al., 2001). This characteristic may explain the 
aggregation of -Lg in water, after 14 days of storage at low temperature. This effect 
was not observable for -Lg under simulant conditions. The presence of acetic acid 
could enhance the charge density and electrostatic repulsion between proteins (Liao 
et al., 2010), preventing protein aggregation during storage time. These micrographs   
also   confirm   that   the   particle   diameter   of -Lg nanostructures remained 
constant under simulant conditions (when comparisons were made with time 0, Fig. 
4), suggesting that proteins remain stable during this 14 days period. Thus, TEM 
micrographs allowed confirming the lack of structural  changes on -Lg nanocomplex 
14 
 
during the stability assay, under these food simulant conditions. 
Despite -Lg stability under simulant conditions, a riboflavin release profile 
was obtained. Results regarding release of riboflavin are shown in Fig. 5 and 
allowed to determine if -Lg could serve as a protective carrier for this vitamin 
during a given storage period (shelf life). 
The results shown in Fig. 5 are in accordance with TEM and DLS results. Since 
-Lg did not show significant structural changes over time under food simulant 
conditions, it was expected that riboflavin remained associated to -Lg in the food 
simulant as much as in water. Therefore, -Lg gradually released its riboflavin 
content and, at day 7, the complete riboflavin release occurred. No significant 
differences (p > 0.05) were observed when comparing water and simulant results, 
confirming once more that -Lg was resistant to food simulant conditions. 
 
4. Conclusions 
 
Stable and homogenous -Lg nanostructures were successfully produced at pH 6 
to act as protective carriers for nutraceuticals (e.g. riboflavin). It was possible to 
conclude that not only -Lg nanostructures have the ability to associate to riboflavin, 
with an association efficiency of 26 ± 1%, but they also serve as protective carriers 
during gastric digestion, releasing the riboflavin content in the appropriate 
absorption location (i.e. small intestine) once -Lg is completely degraded as soon as 
the nanostructures reach the duodenum. Moreover, the results showed that 12% of 
RDD would reach the small intestine if 100 mL of solution was ingested and, thus, 
this nanostructure could be added to food products to act as a food supplement, in 
order to help reaching the RDD. 
Results show that -Lg nanostructure is structurally stable for a period of 14 days 
under simulant conditions (i.e. yoghurt). The presence of acetic acid may have 
increase electrostatic repulsion between -Lg, thus preventing its aggregation and 
enhancing its structural stability. However, regarding riboflavin release, -Lg/ 
riboflavin nanocomplex is less stable under similar conditions once riboflavin is fully 
released from protein core after a period of 7 days of storage. 
Further tests in a dynamic GI model (as identical as possible to the human GI 
system) and in Caco-2/HT29-MTX co-cultured cell lines (to mimic, as close as 
possible, human intestinal cells) will be crucial to evaluate the permeability and 
absorption rates of riboflavin and to obtain more accurate results in order to better 
understand and predict the behavior of nanostructured systems under GI simulated 
conditions. It would also be important to study the behavior of -Lg/riboflavin 
nanocomplex under other food  simulant conditions such as beverages  or starch-
based foods, as well  as in a real food matrix. 
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Fig. 1. Native PAGE of -Lg nanostructures loaded with riboflavin at different 
stages of the GI tract: 1- native -Lg (without heat treatment); 2- -Lg/riboflavin 
nanocomplex; 3 and 5 stomach and duodenum control (GES and SIES, 
respectively); 4, 6, 7 and 8 - -Lg/riboflavin nanocomplex in stomach, duodenum 
jejunum and ileum, respectively. 
 
 
Fig. 2. Influence of in vitro gastrointestinal conditions on accessibility of free 
riboflavin and release of riboflavin from -Lg/riboflavin nanocomplex over 
different stages of the GI tract during 5 h of digestion  time. 
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Fig. 3. Structural analysis of -Lg nanocomplex determined by measuring a) 
size, b) PDI and c) -potential via DLS, during a 14 days of storage, in water and 
food simulant conditions. 
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Fig. 4. TEM micrographs of -Lg under water (column A - control) and food 
simulant (column B) conditions, at time 0 (top micrographs) and time 14 (bottom 
micrographs) (scale bar = 200 nm, magnification =  80,000 x). 
 
 
Fig. 5.  Riboflavin release profile in water and food simulant conditions during 
14 days of storage. 
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 Table 1 
In vitro digestion conditions for the different digestion phases, using electrolyte solutions for gastric (GES - NaCl 4.8 g/L, KCl 2.2 
g/L, CaCl2 0.22 g/L and NaHCO3 1.5 g/L) and small intestine (SIES - NaCl 5 g/L, KCl 0.6 g/L and CaCl2 0.25 g/L) conditions 
 
 
Table 2 
Particle size, PDI and -potential values obtained for -Lg nanostructures before and after heating treatment, as well as 
after riboflavin association. 
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Table 3 
Particle size, PDI and -potential values of -Lg/riboflavin nanocomplex at different stages of digestion (0 h e control, 2 h e 
stomach, 3 h e duodenum, 4 h e jejunum and 5 h e ileum). 
 
